CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Spain”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Spain. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Spain. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Spain, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Sanofi, GSK, Almirall, Roche and Boehringer Ingelheim) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche Diagnostic, Essilor, Zimmer Biomet and Grifols)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Spain
  • Porter’s five forces analysis for pharmaceutical and medical devices market of Spain
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities and challenges to growth in the Spanish healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving the Spanish healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Spanish healthcare market

Table of Contents

1 Table of Contents

1.1 List of Figures

1.2 List of Tables

2 Executive Summary

2.1 Executive Summary – Overview

2.2 Key Highlights

2.3 Key ...

1 Table of Contents

1.1 List of Figures

1.2 List of Tables

2 Executive Summary

2.1 Executive Summary – Overview

2.2 Key Highlights

2.3 Key Events: Spanish Pharmaceutical History, 2014–2019

2.4 Key Events: Spanish Pharmaceutical Market

2.5 Impact of Brexit on the Spanish Healthcare System

2.6 Key Events: M&A, VF & PE Deals, Global Pharmaceutical Market, 2018–2019

2.7 Key Events: Mergers and Acquisitions

2.8 Country Profile, Spain, 2018

3 Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels

3.5 Pharmaceutical Market – Market Segments

3.6 Pharmaceutical Market – Top Five Disease Areas

3.7 Pharmaceutical Market – Major Players

4 Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Device Market – Top Five Segments

4.3 Medical Device Market – Diagnostic Market

4.4 Medical Device Market – Major Players

5 Pharmaceutical and Medical Device Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6 Deal analysis

6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, Spain

6.2 Deal Analysis: M&A, VF and PE Deals, Medical Device Market, Spain

7 Pharmaceutical and Medical Device Market – Porter’s Five Forces Analysis

7.1 Pharmaceutical Market, Spain – Porter’s Five Forces Analysis

7.2 Medical Device Market, Spain – Porter’s Five Forces Analysis

8 Market Access

8.1 Overview of Healthcare System, Spain

8.2 Reimbursement Process, Spain

8.2.1 Overview of Insurance, Spain

8.2.2 Healthcare Spending and Medical Products Price Index, Spain

8.2.3 Pricing Policies, Spain

8.3 Regulatory Landscape, Spain

8.3.1 Marketing Authorization for Pharmaceutical Products, EU

8.3.2 Market Authorization for Pharmaceutical Drugs, Spain

8.3.3 Market Authorization for Medical Devices, Spain

8.3.4 Intellectual Property Rights, Patent, Spain

8.3.5 Intellectual Property Rights, Trademark, Spain

8.3.6 Clinical Trial Regulations, Spain

8.3.7 Pharmaceutical Advertising Regulations, Spain

8.3.8 Labeling and Packaging Regulations, Spain

9 Country Healthcare Landscape

9.1 Healthcare Policy Highlights

9.2 Healthcare Facilities

9.3 Healthcare Parameters

9.4 Environmental Health

9.5 Healthcare Personnel

9.6 Disease Burden

9.7 Healthcare Expenditure

9.7.1 Healthcare Expenditure – Overview

9.7.2 Share of Public and Private Sectors

10 Trade Associations, Spain

11 Trade Fairs, Spain

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.1.4 Expert Panel

13.2 Bibliography

13.3 Contact Us

13.4 Disclaimer

List of Tables

Table 1: Major Self-Medication Product Groups, Revenue ($M), Spain, 2017

Table 2: Top Five Therapeutic Areas by Sales Through Retail Pharmacies ($B), Spain, 2017

Table ...

Table 1: Major Self-Medication Product Groups, Revenue ($M), Spain, 2017

Table 2: Top Five Therapeutic Areas by Sales Through Retail Pharmacies ($B), Spain, 2017

Table 3: Diabetes Care Devices Market, Spain, Revenue ($M) and Market Share (%) of Major Companies, 2015

Table 4: IVD Devices Market, Spain, Revenue ($M) and Market Share (%) of Major Companies, 2018

Table 5: Ophthalmic Devices Market, Spain, Revenue ($M) and Market Share (%) of Major Companies, 2015

Table 6: Orthopedic Devices Market, Spain, Revenue ($M) and Market Share (%) of Major Companies, 2018

Table 7: Hospital Supplies Market, Spain, Revenue ($M) and Market Share (%) of Major Companies, 2017

Table 8: Patent Fees, Spain, 2019

Table 9: Trademark Fees, Spain, 2019

Table 10: Clinical Trial Fees, Spain, 2019

Table 11:Packaging information, Spain, 2017

Table 12: Trade Fairs, Spain, 2019

List of Figures

Figure 1: Pharmaceutical Market, Spain, Revenue ($B), 2010–2017

Figure 2: Medical Device Market, Spain, Revenue ($B), 2015–2020

Figure 3: Country Profile, Spain, 2018

Figure 4: ...

Figure 1: Pharmaceutical Market, Spain, Revenue ($B), 2010–2017

Figure 2: Medical Device Market, Spain, Revenue ($B), 2015–2020

Figure 3: Country Profile, Spain, 2018

Figure 4: Pharmaceutical Market, Spain, Revenue ($B), 2010–2017

Figure 5: Pharmaceutical Market, Spain, Revenue Forecast ($B), 2018–2022

Figure 6: Pharmaceutical Exports ($B), Spain, 2010–2017

Figure 7: Top Export Partners, Spain, 2017

Figure 8: Pharmaceutical Imports ($B), Spain, 2010–2017

Figure 9: Top Import Partners, Spain, 2017

Figure 10: Generic Drugs Market (% share), Spain, 2008–2016

Figure 11: Recent Developments in the Spanish Biosimilar Industry, Spain, 2018–2019

Figure 12: Pharmaceutical OTC Market, Spain, Revenue ($B), 2010–2017

Figure 13: Major Self-Medication Product Groups, Revenue ($M), Spain, 2017

Figure 14: Top Five Therapeutic Areas by Sales Through Retail Pharmacies ($B), Spain, 2017

Figure 15: Pharmaceutical Market, Major Players, 2017

Figure 16: Medical Device Market, Spain, Revenue ($B), 2015–2020

Figure 17: Medical Device Market, Spain, Revenue Forecast ($B), 2021–2025

Figure 18: Medical Device Market, Spain, Revenue by Segment ($B), 2018

Figure 19: Diabetes Care Devices Market, Spain, Revenue ($B), 2015–2022

Figure 20: Diabetes Care Devices Market, Spain, Market Share of Major Players (%), 2015

Figure 21: In Vitro Diagnostics Devices Market, Spain, Revenue ($B), 2015–2022

Figure 22: In Vitro Diagnostics Devices Market, Spain, Market Share of Major Companies (%), 2016

Figure 23: Ophthalmic Devices Market, Spain, Revenue ($B), 2015–2022

Figure 24: Ophthalmic Devices Market, Spain, Market Share of Major Players (%), 2017

Figure 25: Orthopedic Devices Market, Spain, Revenue ($B), 2015–2022

Figure 26: Orthopedic Devices Market, Spain, Market Share of Major Players (%), 2016

Figure 27: Hospital Supplies Market, Spain, Revenue ($B), 2015–2022

Figure 28: Hospital Supplies Market, Spain, Market Share of Major Players (%), 2017

Figure 29: Diagnostic Market, Spain, Revenue ($B), 2015–2020

Figure 30: Diagnostic Market, Spain, Revenue ($B), 2021–2025

Figure 31: Medical Device Market, Spain, Revenue ($B) of Major Companies, 2017

Figure 32: Deal Value and Deal Count, Pharmaceutical Market, Spain, 2018–2019

Figure 33: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Spain, 2018–2019

Figure 34: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Spain, 2018–2019

Figure 35: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Spain, 2018–2019

Figure 36: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, Spain, 2018–2019

Figure 37: M&A Deals by Therapy Area, Pharmaceutical Market, Spain, 2018–2019 (by value and by number)

Figure 38: Venture Financing Deals by Therapy Area, Pharmaceutical Market Spain, 2018–2019(by value and by number)

Figure 39: Medical Device Market Deals (by deal value, $M), Spain, 2018

Figure 40: Private Equity Deals by Therapy Area, Pharmaceutical Market, Spain, 2018–2019(by value and by number)

Figure 41: Medical Device Market Deals (by deal count), Spain, 2018–2019

Figure 42: Medical Device Market Deals Share (by deal count), Spain, 2018–2019

Figure 43: Medical Device Market Deals Share (by deal value), Spain, 2018–2019

Figure 44: Medical Device Market Deals Share (by deal value), Spain, 2018–2019

Figure 45: Medical Device Market Deals, Spain, Top Therapy Area by Deal Value, 2018–2019

Figure 46: Medical Device Market Deals, Spain, Top Therapy Area by Deal Number, 2018–2019

Figure 47: Medical Device Market Deals, Spain, M&A Deals by Therapy Area, 2018–2019

Figure 48: Medical Device Market Deals, Spain, Venture Financing Deals by Therapy Area, 2018–2019

Figure 49: Medical Device Market Deals, Spain, Private Equity Deals by Therapy Area, 2018–2019

Figure 50: Organization of the Health System, Spain, 2018

Figure 51: Reimbursement Pricing for New Drugs, Spain, 2018

Figure 52: Voluntary Health Insurance (%), Spain, 2017

Figure 53: Out-of-Pocket Expenditure (% of total expenditure on health), Spain, 2010–2017

Figure 54: Annual Rate of Change (%), Medical Products Price Index, Spain, 2010–2018

Figure 55: AEMPS, Organization Chart, 2018

Figure 56: Drug Authorization Procedures, EU, 2019

Figure 57: Centralized Procedure, Spain, 2018

Figure 58: Decentralized Procedure, Spain, 2018

Figure 59: Mutual Recognition Procedure, Spain, 2018

Figure 60: Drug Approval Process Timeline, Spain, 2018

Figure 61: Conformity Assessment of Class I Medical Devices, EU, 2018

Figure 62: Conformity Assessment of Class IIa Medical Devices, EU, 2018

Figure 63: Conformity Assessment of Class IIb Medical Devices, EU, 2018

Figure 64: Conformity Assessment of Class III Medical Devices, EU, 2018

Figure 65: Patent Approval Process, Spain, 2018

Figure 66: Hospitals (number), Spain, 2010–2017

Figure 51: Reimbursement Pricing for New Drugs, Spain, 2018

Figure 52: Voluntary Health Insurance (%), Spain, 2017

Figure 53: Out-of-Pocket Expenditure (% of total expenditure on health), Spain, 2010–2017

Figure 54: Annual Rate of Change (%), Medical Products Price Index, Spain, 2010–2018

Figure 55: AEMPS, Organization Chart, 2018

Figure 56: Drug Authorization Procedures, EU, 2019

Figure 57: Centralized Procedure, Spain, 2018

Figure 58: Decentralized Procedure, Spain, 2018

Figure 59: Mutual Recognition Procedure, Spain, 2018

Figure 60: Drug Approval Process Timeline, Spain, 2018

Figure 61: Conformity Assessment of Class I Medical Devices, EU, 2018

Figure 62: Conformity Assessment of Class IIa Medical Devices, EU, 2018

Figure 63: Conformity Assessment of Class IIb Medical Devices, EU, 2018

Figure 64: Conformity Assessment of Class III Medical Devices, EU, 2018

Figure 65: Patent Approval Process, Spain, 2018

Figure 66: Hospitals (number), Spain, 2010–2017

Figure 67: Hospitals by Type (number), Spain, 2010–2017

Figure 68: Diagnostic Equipment (installed base), Spain, 2010–2017

Figure 69: Hospital Beds (per 1,000 population), Spain, 2010–2017

Figure 70: Acute Care Hospital Beds (per 1,000 population), Spain, 2010–2017

Figure 71: Psychiatric Care Hospital Beds (per 1,000 population), Spain, 2010–2017

Figure 72: Life Expectancy (in years), Spain, 2010–2017

Figure 73: Immunization Rate (%), Spain, 2010–2016

Figure 74: PM2.5 (µg per m3), Spain, 2010–2017

Figure 75: CO2 Emissions (metric tons per capita), Spain, 2010–2017

Figure 76: Physicians (per 1,000 population), Spain, 2010-2017

Figure 77: Nurses (per 1,000 population), Spain, 2010-2017

Figure 78: Dentists, (per 1,000 population), Spain, 2010-2017

Figure 79: Pharmacists, (per 1,000 population), Spain, 2010-2017

Figure 80: Major Causes of Mortality (Death rate [per 100,000 population]), Spain, 2016

Figure 81: Major Causes of Male Mortality (Death rate [per 100,000 population]), Spain, 2016

Figure 82: Major Causes of Female Mortality (Death rate [per 100,000 population]), Spain, 2016

Figure 83: Disability-Adjusted Life Years by Major Disease (‘000), Spain, 2016

Figure 84: Healthcare Expenditure as Percentage of GDP (%), Spain, 2011–2017

Figure 85: Health Expenditure Share (% of total health spending), Spain, 2011–2017

Figure 86: Healthcare spending as per providers (%), Spain, 2016

Figure 87: Pharmaceutical Spending (% of total health spending), Spain, 2011–2016

Figure 88: Opportunities & Challenges, Spain

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports

The extent of coverage across marketed and pipeline products, as well as pre-clinical and discovery products, is outstanding

  Imclone Systems